Myrtle S Potter's SEC Filing for Guardant Health, Inc.

Myrtle S Potter, a director at Guardant Health, Inc., has filed a Form 144 with the SEC. The filing details the planned sale of 26 shares of common stock, acquired through a restricted stock lapse on October 15, 2025. The shares are to be sold on October 17, 2025, with an aggregate market value of $1,741. The filing also reports three recent transactions where Potter sold 26 shares each in July, August, and September 2025, with gross proceeds of $1,253, $1,535, and $1,446 respectively. The transactions were executed through Charles Schwab & Co., Inc. The filing indicates no gifts were involved in these transactions.